{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:46:08Z","timestamp":1777376768230,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:00:00Z","timestamp":1503619200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s10194-017-0801-7","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T12:50:56Z","timestamp":1503665456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users"],"prefix":"10.1186","volume":"18","author":[{"given":"Gabriele S.","family":"Merki-Feld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Epple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Caveng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Imthurn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhardt","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Sandor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas R.","family":"Gantenbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,25]]},"reference":[{"issue":"5","key":"801_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1468-2982.2009.01944.x","volume":"30","author":"TW Victor","year":"2010","unstructured":"Victor TW, Hu X, Campbell J, White RE, Buse DC, Lipton RB (2010) Association between migraine, anxiety and depression. Cephalalgia 30(5):567\u2013575","journal-title":"Cephalalgia"},{"key":"801_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1212\/WNL.22.4.355","volume":"22","author":"B Somerville","year":"1972","unstructured":"Somerville B (1972) The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 22:355\u2013365","journal-title":"Neurology"},{"issue":"4","key":"801_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1526-4610.1989.hed22904233.x","volume":"29","author":"G Nattero","year":"1989","unstructured":"Nattero G, Allais G, De Lorenzo C et al (1989) Relevance of prostaglandins in true menstrual migraine. Headache 29(4):233\u2013238","journal-title":"Headache"},{"issue":"9","key":"801_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache S","year":"2013","unstructured":"Headache Classification Committee of the International Headache S (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33(9):629\u2013808","journal-title":"Cephalalgia"},{"key":"801_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1129-2377-14-7","volume":"14","author":"Y Hu","year":"2013","unstructured":"Hu Y, Guan X, Fan L, Jin L (2013) Triptans in prevention of menstrual migraine: a systematic review with meta-analysis. J Headache Pain 14:7","journal-title":"J Headache Pain"},{"issue":"9","key":"801_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1468-2982.2004.00741.x","volume":"24","author":"F Granella","year":"2004","unstructured":"Granella F, Sances G, Allais G et al (2004) Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 24(9):707\u2013716","journal-title":"Cephalalgia"},{"issue":"14","key":"801_CR7","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/0333102415575723","volume":"35","author":"KG Vetvik","year":"2015","unstructured":"Vetvik KG, Benth JS, MacGregor EA, Lundqvist C, Russell MB (2015) Menstrual versus non-menstrual attacks of migraine without aura in women with and without menstrual migraine. Cephalalgia 35(14):1261\u20131268","journal-title":"Cephalalgia"},{"key":"801_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s10194-015-0503-y","volume":"16","author":"JM Pavlovic","year":"2015","unstructured":"Pavlovic JM, Stewart WF, Bruce CA et al (2015) Burden of migraine related to menses: results from the AMPP study. J Headache Pain. 16:24","journal-title":"J Headache Pain."},{"issue":"15","key":"801_CR9","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1517\/14656566.2011.602342","volume":"12","author":"L Lionetto","year":"2011","unstructured":"Lionetto L, Fiorillo M, Martelletti P (2011) Efficacy and tolerability of almotriptan in menstrual migraine: a comment. Expert Opin Pharmacother 12(15):2279\u20132281","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"801_CR10","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/head.12640","volume":"55","author":"C Nierenburg Hdel","year":"2015","unstructured":"Nierenburg Hdel C, Ailani J, Malloy M, Siavoshi S, Hu NN, Yusuf N (2015) Systematic review of preventive and acute treatment of menstrual migraine. Headache 55(8):1052\u20131071","journal-title":"Headache"},{"issue":"2","key":"801_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/0333102415584308","volume":"36","author":"TW Ho","year":"2016","unstructured":"Ho TW, Ho AP, Ge YJ et al (2016) Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine. Cephalalgia 36(2):148\u2013161","journal-title":"Cephalalgia"},{"issue":"7","key":"801_CR12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1526-4610.2007.00855.x","volume":"47","author":"LK Mannix","year":"2007","unstructured":"Mannix LK, Savani N, Landy S et al (2007) Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. Headache 47(7):1037\u20131049","journal-title":"Headache"},{"key":"801_CR13","doi-asserted-by":"crossref","unstructured":"Allais G, Sanchez del Rio M, Diener HC, et al. Perimenstrual migraines and their response to preventive therapy with topiramate. Cephalalgia 2011;31(2):152\u2013160","DOI":"10.1177\/0333102410378049"},{"issue":"7","key":"801_CR14","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/pme.12788","volume":"16","author":"EL Spierings","year":"2015","unstructured":"Spierings EL, Padamsee A (2015) Menstrual-cycle and menstruation disorders in episodic vs chronic migraine: an exploratory study. Pain Med 16(7):1426\u20131432","journal-title":"Pain Med"},{"issue":"2","key":"801_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1212\/01.WNL.0000133134.68143.2E","volume":"63","author":"EA MacGregor","year":"2004","unstructured":"MacGregor EA, Hackshaw A (2004) Prevalence of migraine on each day of the natural menstrual cycle. Neurology 63(2):351\u2013353","journal-title":"Neurology"},{"issue":"10","key":"801_CR16","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1212\/WNL.55.10.1517","volume":"55","author":"WF Stewart","year":"2000","unstructured":"Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD (2000) Menstrual cycle and headache in a population sample of migraineurs. Neurology 55(10):1517\u20131523","journal-title":"Neurology"},{"issue":"4","key":"801_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1526-4610.2010.01625.x","volume":"50","author":"EA MacGregor","year":"2010","unstructured":"MacGregor EA, Victor TW, Hu X et al (2010) Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache 50(4):528\u2013538","journal-title":"Headache"},{"issue":"4","key":"801_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1089\/jwh.2013.4485","volume":"23","author":"AL Coffee","year":"2014","unstructured":"Coffee AL, Sulak PJ, Hill AJ, Hansen DJ, Kuehl TJ, Clark JW (2014) Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines. J Women's Health (Larchmt) 23(4):310\u2013317","journal-title":"J Women's Health (Larchmt)"},{"issue":"8","key":"801_CR19","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ejpain.2011.02.003","volume":"15","author":"D Lieba-Samal","year":"2011","unstructured":"Lieba-Samal D, Wober C, Frantal S et al (2011) Headache, menstruation and combined oral contraceptives: a diary study in 184 women with migraine. Eur J Pain 15(8):852\u2013857","journal-title":"Eur J Pain"},{"issue":"5","key":"801_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11916-012-0280-0","volume":"16","author":"B Casolla","year":"2012","unstructured":"Casolla B, Lionetto L, Candela S et al (2012) Treatment of perimenstrual migraine with triptans: an update. Curr Pain Headache Rep 16(5):445\u2013451","journal-title":"Curr Pain Headache Rep"},{"key":"801_CR21","volume-title":"Ghiotto N, et al","author":"M Viana","year":"2015","unstructured":"Viana M, Sances G (2015) Ghiotto N, et al. Variability of the characteristics of a migraine attack within patients, Cephalalgia"},{"issue":"11","key":"801_CR22","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/j.1468-2982.2009.01840.x","volume":"29","author":"JL Brandes","year":"2009","unstructured":"Brandes JL, Poole A, Kallela M et al (2009) Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks. Cephalalgia 29(11):1133\u20131148","journal-title":"Cephalalgia"},{"issue":"Suppl 2","key":"801_CR23","doi-asserted-by":"publisher","first-page":"s162","DOI":"10.1007\/s10072-005-0435-4","volume":"26","author":"F Moschiano","year":"2005","unstructured":"Moschiano F, Allais G, Grazzi L et al (2005) Naratriptan in the short-term prophylaxis of pure menstrual migraine. Neurol Sci 26(Suppl 2):s162\u2013s166","journal-title":"Neurol Sci"},{"issue":"2","key":"801_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1212\/01.WNL.0000134620.30129.D6","volume":"63","author":"SD Silberstein","year":"2004","unstructured":"Silberstein SD, Elkind AH, Schreiber C, Keywood C (2004) A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 63(2):261\u2013269","journal-title":"Neurology"},{"key":"801_CR25","doi-asserted-by":"crossref","unstructured":"Tepper NK, Whiteman MK, Zapata LB, Marchbanks PA, Curtis KM (2016) Safety of hormonal contraceptives among women with migraine: a systematic review. Contraception","DOI":"10.1016\/j.contraception.2016.04.016"},{"key":"801_CR26","doi-asserted-by":"publisher","first-page":"b2890","DOI":"10.1136\/bmj.b2890","volume":"339","author":"O Lidegaard","year":"2009","unstructured":"Lidegaard O, Lokkegaard E, Svendsen AL, Agger C (2009) Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 339:b2890","journal-title":"BMJ"},{"issue":"24","key":"801_CR27","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","volume":"366","author":"O Lidegaard","year":"2012","unstructured":"Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N (2012) Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 366(24):2257\u20132266","journal-title":"N Engl J Med"},{"issue":"3","key":"801_CR28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2265.2007.03046.x","volume":"68","author":"GS Merki-Feld","year":"2008","unstructured":"Merki-Feld GS, Imthurn B, Seifert B (2008) Effects of the progestagen-only contraceptive implant Implanon on cardiovascular risk factors. Clin Endocrinol 68(3):355\u2013360","journal-title":"Clin Endocrinol"},{"key":"801_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ejogrb.2014.10.029","volume":"183","author":"M Morotti","year":"2014","unstructured":"Morotti M, Remorgida V, Venturini PL, Ferrero S (2014) Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study. Eur J Obstet Gynecol Reprod Biol 183:178\u2013182","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"801_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/0333102412473373","volume":"33","author":"GS Merki-Feld","year":"2013","unstructured":"Merki-Feld GS, Imthurn B, Langner R, Sandor PS, Gantenbein AR (2013) Headache frequency and intensity in female migraineurs using desogestrel-only contraception: a retrospective pilot diary study. Cephalalgia 33(5):340\u2013346","journal-title":"Cephalalgia"},{"issue":"5","key":"801_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3109\/13625187.2013.814769","volume":"18","author":"GS Merki-Feld","year":"2013","unstructured":"Merki-Feld GS, Imthurn B, Seifert B, Merki LL, Agosti R, Gantenbein AR (2013) Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine. Eur J Contracept Reprod Health Care 18(5):394\u2013400","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"801_CR32","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s10194-015-0522-8","volume":"16","author":"GS Merki-Feld","year":"2015","unstructured":"Merki-Feld GS, Imthurn B, Langner R, Seifert B, Gantenbein AR (2015) Positive effects of the progestin desogestrel 75 mug on migraine frequency and use of acute medication are sustained over a treatment period of 180 days. J Headache Pain. 16:522","journal-title":"J Headache Pain."},{"issue":"1","key":"801_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s10194-017-0752-z","volume":"18","author":"H Witteveen","year":"2017","unstructured":"Witteveen H, van den Berg P, Vermeulen G (2017) Treatment of menstrual migraine; multidisciplinary or mono-disciplinary approach. J Headache Pain. 18(1):45","journal-title":"J Headache Pain."}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-017-0801-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-017-0801-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-017-0801-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T08:22:46Z","timestamp":1602836566000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-017-0801-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,25]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1186\/s10194-017-0801-7","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,25]]},"article-number":"91"}}